NCT06299163
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06299163
Title NM32-2668 in Adult Patients With Selected Advanced Solid Tumors
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Numab Therapeutics AG
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Alabama at Birmingham Birmingham Alabama 35294 United States Details
USC Norris Comprehensive Cancer Center Los Angeles California 90033 United States Details
The University of Chicago Medical Center (UCMC) Chicago Illinois 60637 United States Details
Duke University Durham North Carolina 27710 United States Details
Cleveland Clinic Cleveland Ohio 44195 United States Details
University of Pittsburgh Medical Center (UPMC) - Hillman Cancer Center Pittsburgh Pennsylvania 15232 United States Details
Lifespan Cancer Institute at Rhode Island Hospital Providence Rhode Island 02903 United States Details
Medical University of South Carolina (MUSC) Charleston South Carolina 29425 United States Details
Vanderbilt University Medical Center Nashville Tennessee 37232 United States Details
Mary Crowley Cancer Research Dallas Texas 75230 United States Details
Froedtert Hospital and the Medical College of Wisconsin Milwaukee Wisconsin 53226 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field